DK527186D0 - Bronchodilaterende farmaceutisk praeparat - Google Patents

Bronchodilaterende farmaceutisk praeparat

Info

Publication number
DK527186D0
DK527186D0 DK527186A DK527186A DK527186D0 DK 527186 D0 DK527186 D0 DK 527186D0 DK 527186 A DK527186 A DK 527186A DK 527186 A DK527186 A DK 527186A DK 527186 D0 DK527186 D0 DK 527186D0
Authority
DK
Denmark
Prior art keywords
chodilating
source
pharmaceutical preparation
pharmaceutically acceptable
weight
Prior art date
Application number
DK527186A
Other languages
English (en)
Other versions
DK527186A (da
Inventor
Craig Allan Paul Dance Saxton
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK527186D0 publication Critical patent/DK527186D0/da
Publication of DK527186A publication Critical patent/DK527186A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK527186A 1985-11-06 1986-11-05 Bronchodilaterende farmaceutisk praeparat DK527186A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/795,689 US4601897A (en) 1985-11-06 1985-11-06 Prazosin-pirbuterol combination for bronchodilation

Publications (2)

Publication Number Publication Date
DK527186D0 true DK527186D0 (da) 1986-11-05
DK527186A DK527186A (da) 1987-05-07

Family

ID=25166193

Family Applications (1)

Application Number Title Priority Date Filing Date
DK527186A DK527186A (da) 1985-11-06 1986-11-05 Bronchodilaterende farmaceutisk praeparat

Country Status (14)

Country Link
US (1) US4601897A (da)
EP (1) EP0222575B1 (da)
JP (1) JPS62135424A (da)
AT (1) ATE59295T1 (da)
AU (1) AU567018B2 (da)
CA (1) CA1284107C (da)
DE (1) DE3676640D1 (da)
DK (1) DK527186A (da)
ES (1) ES2036174T3 (da)
GR (1) GR3001420T3 (da)
IE (1) IE59327B1 (da)
IL (1) IL80476A0 (da)
NZ (1) NZ218175A (da)
ZA (1) ZA868427B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA878182B (en) * 1986-11-05 1988-05-02 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
US4868182A (en) * 1986-11-05 1989-09-19 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action
US5776434A (en) * 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
CA2604735A1 (en) 2005-04-12 2006-10-19 Elan Pharma International Limited Nanoparticulate quinazoline derivative formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3723434A (en) * 1970-07-17 1973-03-27 Pfizer Piperazino isoquinoline bronchodilators
US3786160A (en) * 1971-02-16 1974-01-15 Pfizer Use of 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)-pyridines as bronchodilators
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4175128A (en) * 1979-01-03 1979-11-20 Pfizer Inc. Method for treating congestive heart failure
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
DE3235565A1 (de) * 1982-09-25 1984-03-29 Boehringer Ingelheim KG, 6507 Ingelheim Piperidinderivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
AU567018B2 (en) 1987-11-05
IL80476A0 (en) 1987-02-27
NZ218175A (en) 1989-04-26
ZA868427B (en) 1988-06-29
EP0222575A1 (en) 1987-05-20
GR3001420T3 (en) 1992-09-25
JPS62135424A (ja) 1987-06-18
JPH0524890B2 (da) 1993-04-09
IE862911L (en) 1987-05-06
CA1284107C (en) 1991-05-14
DE3676640D1 (de) 1991-02-07
EP0222575B1 (en) 1990-12-27
ATE59295T1 (de) 1991-01-15
DK527186A (da) 1987-05-07
AU6483286A (en) 1987-05-21
ES2036174T3 (es) 1993-05-16
US4601897A (en) 1986-07-22
IE59327B1 (en) 1994-02-09

Similar Documents

Publication Publication Date Title
ES521422A0 (es) Procedimiento para la obtencion de derivados de carboxilamida n-glicosilados.
SE8702907D0 (sv) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
DK527186D0 (da) Bronchodilaterende farmaceutisk praeparat
ES507807A0 (es) Procedimiento para la obtencion de derivados triciclicos de citosina.
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
ES8306483A1 (es) Procedimiento de preparacion de las dibezooxepinas sustituidas y de sus sales de adicion con un acido mineral u organico
DE3361990D1 (en) Alkylene-bridged guanidino-thiazole derivatives, method for their preparation and their use as medicaments
ATE3552T1 (de) Verfahren zur herstellung von phosphono-hydroxy- essigsaeure und salzen derselben sowie diese enthaltende autivirale mittel.
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
ES2064652T3 (es) Derivados de naftaleno- y tetrahidronaftaleno-gem-difosfonato.
DK0541726T3 (da) Vækstfaktorsammensætninger, fremstilling og anvendelse
ATE127455T1 (de) Inhibitoren der calciumaufnahme.
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
SE8603517L (sv) Heterocykliska foreningar och deras framstellning och farmaceutiska formuleringar
RU92016559A (ru) Производные диалкокси-пиридинилбензимидазола, фармацевтическая композиция, способ ингибирования или лечения, способ их получения, применение и промежуточные соединения

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment